Related Experiment Video
Updated: Jun 14, 2025

11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
13.7K
Difference in activated partial thromboplastin time values with two different reagents according to C-reactive
Yuya Ishihara1, Hiroki Doi2, Seiko Sato1
1Department of Clinical Laboratory, Fujita Health University Hospital, Toyoake, Japan.
Laboratory Medicine
|August 30, 2024
Summary
Activated partial thromboplastin time (APTT) reagent differences can affect results. This study found that prolonged APTT (activated partial thromboplastin time) correlated with C-reactive protein (CRP) levels, potentially indicating transient lupus anticoagulant (LA) effects.
Area of Science:
- Clinical Chemistry
- Hematology
- Diagnostic Reagents
Background:
- Activated partial thromboplastin time (APTT) assay results are influenced by reagent composition.
- Discrepancies in APTT measurements necessitate investigation into underlying causes.
Purpose of the Study:
- To investigate a large cohort of specimens to identify the causes of discrepancies in APTT measurements between different reagents.
- To determine the correlation between APTT variations and clinical parameters such as C-reactive protein (CRP).
Main Methods:
- Analysis of 18,994 coagulation tests performed between May 2020 and December 2020.
- Comparison of APTT results using two different reagents: HemosIL SynthASil APTT (APTT-SS) and Coagpia APTT-N (APTT-N).
- Cross-mixing tests (CMT) were performed on selected subjects to investigate potential lupus anticoagulant (LA) interference.
Main Results:
- 451 patients showed prolonged APTT-N with an APTT-N/SS ratio >1.3.
- A significant positive correlation was observed between C-reactive protein (CRP) levels (≥1.4 mg/L) and the APTT-N/SS ratio.
- Cross-mixing tests suggested transient lupus anticoagulant (LA) involvement in 17 out of 28 non-anticoagulated subjects, potentially linked to CRP levels.
Conclusions:
- Prolongation of APTT-N is correlated with CRP levels and may involve transient lupus anticoagulant (LA) interference.
- Assay reagent reactivity varies, impacting APTT results.
- Further investigation for LA is recommended when suspected, considering patient background and CRP levels.

